Skip to content

Clinical trials

Phase 2 Acute Coronary Syndrome trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 2 Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20112
20152
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cerenis Therapeutics, SA2
Astellas Pharma Europe B.V.1
Biopure Corporation1
GlaxoSmithKline1
Janssen Research & Development, LLC1
OrbusNeich1
St. Antonius Hospital1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome9
Myocardial Infarction3
Angina, Unstable2
Atherosclerosis1
Coronary Artery Disease1
Coronary Occlusion1
Myocardial Ischemia1
Non-ST Elevated Myocardial Infarction1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.